Ontario Teachers Pension Plan Board Has $1.43 Million Holdings in DaVita Inc. (NYSE:DVA)

Ontario Teachers Pension Plan Board lessened its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 37.0% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 8,744 shares of the company's stock after selling 5,138 shares during the quarter. Ontario Teachers Pension Plan Board's holdings in DaVita were worth $1,433,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of DaVita by 1.5% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,759 shares of the company's stock valued at $776,000 after acquiring an additional 70 shares in the last quarter. Wedmont Private Capital boosted its position in shares of DaVita by 4.4% in the third quarter. Wedmont Private Capital now owns 1,776 shares of the company's stock worth $280,000 after buying an additional 75 shares during the period. Blue Trust Inc. grew its stake in shares of DaVita by 58.6% in the second quarter. Blue Trust Inc. now owns 211 shares of the company's stock valued at $29,000 after buying an additional 78 shares in the last quarter. First Trust Direct Indexing L.P. raised its holdings in shares of DaVita by 2.9% during the 3rd quarter. First Trust Direct Indexing L.P. now owns 3,051 shares of the company's stock valued at $500,000 after buying an additional 86 shares during the period. Finally, Nisa Investment Advisors LLC lifted its position in DaVita by 0.3% during the 3rd quarter. Nisa Investment Advisors LLC now owns 36,820 shares of the company's stock worth $6,036,000 after acquiring an additional 126 shares in the last quarter. Hedge funds and other institutional investors own 90.12% of the company's stock.

DaVita Price Performance

Shares of DVA stock traded up $1.73 during midday trading on Thursday, reaching $163.13. 121,209 shares of the company were exchanged, compared to its average volume of 819,526. The company's 50 day moving average price is $158.14 and its two-hundred day moving average price is $147.97. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37. The company has a market cap of $13.38 billion, a P/E ratio of 17.41, a PEG ratio of 0.89 and a beta of 0.89. DaVita Inc. has a 12 month low of $97.31 and a 12 month high of $168.50.

DaVita (NYSE:DVA - Get Free Report) last released its earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The firm had revenue of $3.26 billion for the quarter, compared to analyst estimates of $3.25 billion. During the same period in the previous year, the firm earned $2.85 earnings per share. DaVita's revenue was up 4.6% on a year-over-year basis. On average, sell-side analysts expect that DaVita Inc. will post 9.71 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on DVA shares. Bank of America boosted their target price on shares of DaVita from $139.00 to $145.00 and gave the stock an "underperform" rating in a research report on Wednesday, August 7th. UBS Group upped their price objective on shares of DaVita from $169.00 to $175.00 and gave the company a "buy" rating in a research report on Thursday, August 8th. Barclays lifted their target price on DaVita from $150.00 to $164.00 and gave the stock an "equal weight" rating in a research report on Thursday, October 31st. Truist Financial increased their price target on DaVita from $165.00 to $175.00 and gave the company a "hold" rating in a report on Monday, October 7th. Finally, TD Cowen lifted their price objective on DaVita from $139.00 to $150.00 and gave the stock a "hold" rating in a report on Wednesday, July 24th. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $161.80.

Insider Transactions at DaVita

In related news, CFO Joel Ackerman sold 64,029 shares of DaVita stock in a transaction on Tuesday, August 27th. The shares were sold at an average price of $155.06, for a total value of $9,928,336.74. Following the transaction, the chief financial officer now owns 111,481 shares in the company, valued at $17,286,243.86. This trade represents a 36.48 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Javier Rodriguez sold 32,176 shares of the firm's stock in a transaction on Monday, August 26th. The stock was sold at an average price of $155.93, for a total transaction of $5,017,203.68. Following the completion of the sale, the chief executive officer now owns 905,659 shares in the company, valued at approximately $141,219,407.87. The trade was a 3.43 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 156,086 shares of company stock valued at $24,807,161 over the last three months. Company insiders own 2.00% of the company's stock.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.